Background Suicide is a significant public health challenge, underscoring the need for temporally precise and objective biomarkers to identify acute suicide risk. One potential biomarker is electrophysiological brain connectivity measured by magnetoencephalography (MEG). This study used publicly available atlases to es...
Yoojin Lee, Jessica R. Gilbert, Cherise R. Chin Fatt et al.· Frontiers in Psychiatry· 0 citations
Background: Although millions of adults seriously consider suicide each year, clinical trials often exclude individuals experiencing suicidal ideation (SI). This analysis sought to describe the use of a range of psychiatric treatment modalities in individuals with mood disorders with and without a history of suicide at...
Elizabeth D. Ballard, Halla Hafermann, Kelly T. Hurst et al.· Journal of Affective Disorde...· 0 citations
Background Hypothalamic-pituitary-adrenal axis dysregulation is implicated in depression and post-traumatic stress disorder (PTSD), but stress-related neuroendocrine mechanisms that distinguish their comorbid presentation remain poorly understood. Prior work in the broader parent cohort found lower levels of plasma cop...
Hiroe Hu, Benjamin H. Chandler, J. Sloane et al.· Frontiers in Endocrinology· 0 citations
Rigorous RCTs with standardized protocols, larger sample sizes, uniform dosing, and systematic biomarker investigations are needed to clarify ketamine’s neurochemical mechanism and optimize ketamine’s clinical application in treatment-resistant depression.
Balwinder Singh, Hossam M. Ali, Alessandro Miola et al.· Neuropsychopharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.